Adverse events following immunization: Findings from 2017/2018 measles vaccination campaign, Nigeria AEFI reporting in 2017/2018 measles vaccination campaign

被引:1
|
作者
Gbenewei, Ene [1 ]
Nomhwange, Terna [2 ]
Taiwo, Lydia [3 ]
Ayodeji, Isiaka [2 ]
Yusuf, Kabir [1 ]
Baptiste, Anne E. Jean [2 ]
Nsubuga, Peter [4 ]
Braka, Fiona [2 ]
Oteri, Joseph [1 ]
Shuaib, Faisal [1 ]
机构
[1] Natl Primary Hlth Care Dev Agcy, Abuja, Nigeria
[2] WHO Country Off Nigeria, Abuja, Nigeria
[3] AFENET Country Off Nigeria, Abuja, Nigeria
[4] Global Hlth Solut, Atlanta, GA USA
关键词
AEFI (Adverse Event following Immunization); Measles; Supplemental immunization activities; Nigeria;
D O I
10.1016/j.vaccine.2021.02.067
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: An Adverse event following immunization (AEFI) is an untoward medical occurrence following immunization and which may not have a necessary causal relationship with the usage of a vaccine. The World Health Organization categories AEFI into two; serious and non-serious. An AEFI is considered serious if it is life-threatening, requires inpatient hospitalization or results in death. The measles vaccine is safe and effective however because it is a live-attenuated injectable vaccine it is more prone to AEFI as compared to non-injectable vaccines when given in large numbers over a short period as is the nature of measles mass vaccination campaigns (MVC). This article describes Nigeria's experience on AEFI reporting during the 2017/2018 Measles vaccination campaign (MVC). Methods: We reviewed various materials which included the Open Data Kit (ODK) which is an open source smartphone-based data collecting tool, operations room reports, measles campaign tally sheets, AEFI line listing forms, the post measles campaign coverage survey report and the report of the AEFI national expert committee review of the 2017/2018 Nigeria measles MVC. Results: A total of 6,214 suspected cases of AEFI were line listed from all 36 states and the Federal Capital Territory(FCT) during the 2017/2018 MVC with Fever(38%) and pain at injection site the (30%)most common reports. Overall, 99.7% AEFIs were reported to be non-serious AEFIs, with almost all cases resolved fully with no long-term sequalae.. The national incidence of suspected AEFI per 100,000 population was 16.3 with subnational incidence highest in Kebbi state (101.3/100,000) and lowest in Bayelsa state (0.8/100,000). Conclusion: Adequate AEFI reporting, Investigation and management remains important in managing the risk of a disruption of mass campaigns. The deployment of supervisors during campaign may play an important role in improving the identification and reporting of suspected AEFI. Further inquiries about AEFIs during the post campaign coverage evaluation also played a role in improving AEFI reporting and documentation. The real-time, on the spot, follow up by the national operations team helped with decision making and intervention including AEFI investigations and assessments. (C) 2021 World Health Organization. Published by Elsevier Ltd.
引用
收藏
页码:C82 / C88
页数:7
相关论文
共 50 条
  • [41] Impact of an Intervention to Use a Measles, Rubella, and Polio Mass Vaccination Campaign to Strengthen Routine Immunization Services in Nepal
    Wallace, Aaron S.
    Bohara, Rajendra
    Stewart, Steven
    Subedi, Giri
    Anand, Abhijeet
    Burnett, Eleanor
    Giri, Jagat
    Shrestha, Jagat
    Gurau, Suraj
    Dixit, Sameer
    Rajbhandari, Rajesh
    Schluter, W. William
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2017, 216 : S280 - S286
  • [42] Residual susceptibility to measles among young adults in Victoria, Australia following a national targeted measles-mumps-rubella vaccination campaign
    Heath A Kelly
    Heather F Gidding
    Theo Karapanagiotidis
    Jennie A Leydon
    Michaela A Riddell
    [J]. BMC Public Health, 7
  • [43] Residual susceptibility to measles among young adults in Victoria, Australia following a national targeted measles-mumps-rubella vaccination campaign
    Kelly, Heath A.
    Gidding, Heather F.
    Karapanagiotidis, Theo
    Leydon, Jennie A.
    Riddell, Michaela A.
    [J]. BMC PUBLIC HEALTH, 2007, 7 (1)
  • [44] Measles outbreak in complex emergency: estimating vaccine effectiveness and evaluation of the vaccination campaign in Borno State, Nigeria, 2019
    Anne Eudes Jean Baptiste
    John Wagai
    Richard Luce
    Balcha Masresha
    Don Klinkenberg
    Irene Veldhuijzen
    Joseph Oteri
    Boubacar Dieng
    Obianuju Caroline Ikeonu
    Sule Meleh
    Audu Musa
    Fiona Braka
    Susan Hahné
    E. A. M. Sanders
    Eelko Hak
    [J]. BMC Public Health, 21
  • [45] Measles-Rubella Supplementary Immunization Activity Readiness Assessment - India, 2017-2018
    Gurnani, Vandana
    Haldar, Pradeep
    Khanal, Sudhir
    Bhatnagar, Pankaj
    Singh, Balwinder
    Ahmed, Danish
    Samiuddin, Mohammad
    Kumar, Arun
    Negi, Yashika
    Gupta, Satish
    Harvey, Pauline
    Bahl, Sunil
    Dabbagh, Alya
    Alexander, James P.
    Goodson, James L.
    [J]. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2018, 67 (26): : 742 - 746
  • [46] Measles outbreak in complex emergency: estimating vaccine effectiveness and evaluation of the vaccination campaign in Borno State, Nigeria, 2019
    Baptiste, Anne Eudes Jean
    Wagai, John
    Luce, Richard
    Masresha, Balcha
    Klinkenberg, Don
    Veldhuijzen, Irene
    Oteri, Joseph
    Dieng, Boubacar
    Ikeonu, Obianuju Caroline
    Meleh, Sule
    Musa, Audu
    Braka, Fiona
    Hahne, Susan
    Sanders, E. A. M.
    Hak, Eelko
    [J]. BMC PUBLIC HEALTH, 2021, 21 (01)
  • [47] Active follow-up of adverse events following immunization during the mass measles rubella and polio vaccine campaign in Rural Uganda
    Kajungu, Dan Kajungu
    Muhoozi, Michael
    Nambasa, Victoria
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 632 - 633
  • [48] Mass vaccination and educational attainment: Evidence from the 1967-68 Measles Eradication Campaign
    Barteska, Philipp
    Dobkowitz, Sonja
    Olkkola, Maarit
    Rieser, Michael
    [J]. JOURNAL OF HEALTH ECONOMICS, 2023, 92
  • [49] Ocular Adverse Events Following Immunization (AEFI): Data From the Italian Spontaneous Reporting System
    Moretti, U.
    Zanoni, G.
    Lora, R.
    Opri, R.
    Tartaglia, L.
    Trotta, F.
    Ferrazin, F.
    Santuccio, C.
    [J]. DRUG SAFETY, 2012, 35 (10) : 961 - 962
  • [50] ADVERSE EVENTS FOLLOWING MEASLES-MUMPS-RUBELLA VACCINATION. A PROSPECTIVE OBSERVATIONAL STUDY
    Bucsa, Camelia
    Bulik, Noemi
    Farcas, Andreea
    Muresan, Sandra
    Muresan, Ioan
    Oniga, Ovidiu
    [J]. FARMACIA, 2020, 68 (02) : 219 - 224